Global Inhalation Anesthesia Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

January 2026 | 140 pages | ID: G19EB822D57EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Inhalation Anesthesia market size was valued at US$ 1394 million in 2025 and is forecast to a readjusted size of US$ 1840 million by 2032 with a CAGR of 4.0% during review period.

Inhalation anesthesia are volatile liquids or gases administered through the lungs to produce and maintain general anesthesia, allowing patients to become unconscious and insensitive to pain during surgery or certain procedures. They are delivered via an anesthesia machine and vaporizer (for volatile agents) or as a medical gas, mixed with oxygen and sometimes nitrous oxide, and the dose is adjusted by controlling the inspired concentration; because they are absorbed into the bloodstream from the alveoli and then act on the central nervous system, their onset and recovery depend on factors like solubility, ventilation, cardiac output, and how quickly the agent is eliminated through exhalation. Common modern volatile Inhalation anesthesia include sevoflurane, desflurane, and isoflurane, while nitrous oxide is used as an adjunct; these agents are valued for reliable titratability, rapid control of anesthetic depth, and broad applicability across many surgical settings, with selection often guided by patient factors, equipment availability, cost, and safety/environmental considerations. The product has an average price of $200-350 per kilogram and a production volume of approximately 5,000 tons per year.

Upstream for Inhalation anesthesia centers on specialty fluorine and fine-chemical supply chains: petrochemical feedstocks are converted into high-purity fluorinated intermediates and then into volatile agents such as sevoflurane, desflurane, and isoflurane (fluorinated ethers), followed by pharmaceutical-grade purification, stability/impurity control, and GMP fill-finish into vaporizer bottles/cylinders with compliant packaging and QA release. The midstream channel is dominated by regulated pharma distribution (manufacturers ? national wholesalers/GPOs ? hospital pharmacies/OR supply), alongside the anesthesia equipment ecosystem (vaporizers, anesthesia workstations, breathing circuits, and increasingly waste-gas management). Downstream, consumption is primarily in hospitals and ambulatory surgery centers (general anesthesia maintenance and adjunct use), with additional demand from dental sedation services and veterinary anesthesia, and utilization is shaped by clinical protocols (fresh-gas-flow practices, agent selection) and facility infrastructure (central gas systems, scavenging).

The segment is mature and closely tied to surgical volumes, but competitive dynamics are increasingly driven by environmental policy and decarbonization in healthcare, because most inhaled agents are vented largely unchanged and can have high climate impact; professional guidance and research consistently flag desflurane as the most climate-intensive among common volatile agents. As a result, major systems have moved to restrict or decommission desflurane (e.g., NHS England limiting routine use from April 2024) and the EU has rules that prohibit routine desflurane use from 1 January 2026 except when medically justified, pushing formularies toward sevoflurane/isoflurane, lower-flow techniques, and in some cases greater use of TIVA where clinically appropriate. At the same time, suppliers and hospitals are investing in ?greener anesthesia? levers?better monitoring and low-flow optimization, selective nitrous oxide infrastructure reduction, and emerging capture/destruction solutions?so differentiation is shifting from ?just supply? toward emissions-aware clinical support, compliance documentation, and system-level implementation.

This report is a detailed and comprehensive analysis for global Inhalation Anesthesia market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Inhalation Anesthesia market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032

Global Inhalation Anesthesia market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032

Global Inhalation Anesthesia market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032

Global Inhalation Anesthesia market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2021-2026

The Primary Objectives in This Report Are:
  • To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Inhalation Anesthesia
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace
This report profiles key players in the global Inhalation Anesthesia market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baxter, AbbVie, Piramal Critical Care, Fresenius Kabi, Halocarbon, Aspen, Pfizer, Maruishi Pharmaceutical, Jiangsu Hengrui Medicine, Lunan Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Inhalation Anesthesia market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
  • Heptafluoroane
  • Desflurane
  • Isoflurane
  • Others
Market segment by MAC
  • Below 3%
  • Above 3%
Market segment by Chemical Structure
  • Volatile Gases
  • Liquids
Market segment by Application
  • Human Use
  • Animal Use
Major players covered
  • Baxter
  • AbbVie
  • Piramal Critical Care
  • Fresenius Kabi
  • Halocarbon
  • Aspen
  • Pfizer
  • Maruishi Pharmaceutical
  • Jiangsu Hengrui Medicine
  • Lunan Pharmaceutical
  • Hikma Pharmaceuticals
  • HeBei YiPin Pharmaceutical
  • Dechra Pharmaceuticals
  • Life Sciences
  • Zhejiang AngLiKang Pharmaceutical
  • Linde Healthcare
  • Air Liquide
  • Messer
Market segment by region, regional analysis covers
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Inhalation Anesthesia product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Inhalation Anesthesia, with price, sales quantity, revenue, and global market share of Inhalation Anesthesia from 2021 to 2026.

Chapter 3, the Inhalation Anesthesia competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Inhalation Anesthesia breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Inhalation Anesthesia market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Inhalation Anesthesia.

Chapter 14 and 15, to describe Inhalation Anesthesia sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Inhalation Anesthesia Consumption Value by Type: 2021 Versus 2025 Versus 2032
  1.3.2 Heptafluoroane
  1.3.3 Desflurane
  1.3.4 Isoflurane
  1.3.5 Others
1.4 Market Analysis by MAC
  1.4.1 Overview: Global Inhalation Anesthesia Consumption Value by MAC: 2021 Versus 2025 Versus 2032
  1.4.2 Below 3%
  1.4.3 Above 3%
1.5 Market Analysis by Chemical Structure
  1.5.1 Overview: Global Inhalation Anesthesia Consumption Value by Chemical Structure: 2021 Versus 2025 Versus 2032
  1.5.2 Volatile Gases
  1.5.3 Liquids
1.6 Market Analysis by Application
  1.6.1 Overview: Global Inhalation Anesthesia Consumption Value by Application: 2021 Versus 2025 Versus 2032
  1.6.2 Human Use
  1.6.3 Animal Use
1.7 Global Inhalation Anesthesia Market Size & Forecast
  1.7.1 Global Inhalation Anesthesia Consumption Value (2021 & 2025 & 2032)
  1.7.2 Global Inhalation Anesthesia Sales Quantity (2021-2032)
  1.7.3 Global Inhalation Anesthesia Average Price (2021-2032)

2 MANUFACTURERS PROFILES

2.1 Baxter
  2.1.1 Baxter Details
  2.1.2 Baxter Major Business
  2.1.3 Baxter Inhalation Anesthesia Product and Services
  2.1.4 Baxter Inhalation Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.1.5 Baxter Recent Developments/Updates
2.2 AbbVie
  2.2.1 AbbVie Details
  2.2.2 AbbVie Major Business
  2.2.3 AbbVie Inhalation Anesthesia Product and Services
  2.2.4 AbbVie Inhalation Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.2.5 AbbVie Recent Developments/Updates
2.3 Piramal Critical Care
  2.3.1 Piramal Critical Care Details
  2.3.2 Piramal Critical Care Major Business
  2.3.3 Piramal Critical Care Inhalation Anesthesia Product and Services
  2.3.4 Piramal Critical Care Inhalation Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.3.5 Piramal Critical Care Recent Developments/Updates
2.4 Fresenius Kabi
  2.4.1 Fresenius Kabi Details
  2.4.2 Fresenius Kabi Major Business
  2.4.3 Fresenius Kabi Inhalation Anesthesia Product and Services
  2.4.4 Fresenius Kabi Inhalation Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.4.5 Fresenius Kabi Recent Developments/Updates
2.5 Halocarbon
  2.5.1 Halocarbon Details
  2.5.2 Halocarbon Major Business
  2.5.3 Halocarbon Inhalation Anesthesia Product and Services
  2.5.4 Halocarbon Inhalation Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.5.5 Halocarbon Recent Developments/Updates
2.6 Aspen
  2.6.1 Aspen Details
  2.6.2 Aspen Major Business
  2.6.3 Aspen Inhalation Anesthesia Product and Services
  2.6.4 Aspen Inhalation Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.6.5 Aspen Recent Developments/Updates
2.7 Pfizer
  2.7.1 Pfizer Details
  2.7.2 Pfizer Major Business
  2.7.3 Pfizer Inhalation Anesthesia Product and Services
  2.7.4 Pfizer Inhalation Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.7.5 Pfizer Recent Developments/Updates
2.8 Maruishi Pharmaceutical
  2.8.1 Maruishi Pharmaceutical Details
  2.8.2 Maruishi Pharmaceutical Major Business
  2.8.3 Maruishi Pharmaceutical Inhalation Anesthesia Product and Services
  2.8.4 Maruishi Pharmaceutical Inhalation Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.8.5 Maruishi Pharmaceutical Recent Developments/Updates
2.9 Jiangsu Hengrui Medicine
  2.9.1 Jiangsu Hengrui Medicine Details
  2.9.2 Jiangsu Hengrui Medicine Major Business
  2.9.3 Jiangsu Hengrui Medicine Inhalation Anesthesia Product and Services
  2.9.4 Jiangsu Hengrui Medicine Inhalation Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.9.5 Jiangsu Hengrui Medicine Recent Developments/Updates
2.10 Lunan Pharmaceutical
  2.10.1 Lunan Pharmaceutical Details
  2.10.2 Lunan Pharmaceutical Major Business
  2.10.3 Lunan Pharmaceutical Inhalation Anesthesia Product and Services
  2.10.4 Lunan Pharmaceutical Inhalation Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.10.5 Lunan Pharmaceutical Recent Developments/Updates
2.11 Hikma Pharmaceuticals
  2.11.1 Hikma Pharmaceuticals Details
  2.11.2 Hikma Pharmaceuticals Major Business
  2.11.3 Hikma Pharmaceuticals Inhalation Anesthesia Product and Services
  2.11.4 Hikma Pharmaceuticals Inhalation Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.11.5 Hikma Pharmaceuticals Recent Developments/Updates
2.12 HeBei YiPin Pharmaceutical
  2.12.1 HeBei YiPin Pharmaceutical Details
  2.12.2 HeBei YiPin Pharmaceutical Major Business
  2.12.3 HeBei YiPin Pharmaceutical Inhalation Anesthesia Product and Services
  2.12.4 HeBei YiPin Pharmaceutical Inhalation Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.12.5 HeBei YiPin Pharmaceutical Recent Developments/Updates
2.13 Dechra Pharmaceuticals
  2.13.1 Dechra Pharmaceuticals Details
  2.13.2 Dechra Pharmaceuticals Major Business
  2.13.3 Dechra Pharmaceuticals Inhalation Anesthesia Product and Services
  2.13.4 Dechra Pharmaceuticals Inhalation Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.13.5 Dechra Pharmaceuticals Recent Developments/Updates
2.14 Life Sciences
  2.14.1 Life Sciences Details
  2.14.2 Life Sciences Major Business
  2.14.3 Life Sciences Inhalation Anesthesia Product and Services
  2.14.4 Life Sciences Inhalation Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.14.5 Life Sciences Recent Developments/Updates
2.15 Zhejiang AngLiKang Pharmaceutical
  2.15.1 Zhejiang AngLiKang Pharmaceutical Details
  2.15.2 Zhejiang AngLiKang Pharmaceutical Major Business
  2.15.3 Zhejiang AngLiKang Pharmaceutical Inhalation Anesthesia Product and Services
  2.15.4 Zhejiang AngLiKang Pharmaceutical Inhalation Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.15.5 Zhejiang AngLiKang Pharmaceutical Recent Developments/Updates
2.16 Linde Healthcare
  2.16.1 Linde Healthcare Details
  2.16.2 Linde Healthcare Major Business
  2.16.3 Linde Healthcare Inhalation Anesthesia Product and Services
  2.16.4 Linde Healthcare Inhalation Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.16.5 Linde Healthcare Recent Developments/Updates
2.17 Air Liquide
  2.17.1 Air Liquide Details
  2.17.2 Air Liquide Major Business
  2.17.3 Air Liquide Inhalation Anesthesia Product and Services
  2.17.4 Air Liquide Inhalation Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.17.5 Air Liquide Recent Developments/Updates
2.18 Messer
  2.18.1 Messer Details
  2.18.2 Messer Major Business
  2.18.3 Messer Inhalation Anesthesia Product and Services
  2.18.4 Messer Inhalation Anesthesia Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.18.5 Messer Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: INHALATION ANESTHESIA BY MANUFACTURER

3.1 Global Inhalation Anesthesia Sales Quantity by Manufacturer (2021-2026)
3.2 Global Inhalation Anesthesia Revenue by Manufacturer (2021-2026)
3.3 Global Inhalation Anesthesia Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
  3.4.1 Producer Shipments of Inhalation Anesthesia by Manufacturer Revenue ($MM) and Market Share (%): 2025
  3.4.2 Top 3 Inhalation Anesthesia Manufacturer Market Share in 2025
  3.4.3 Top 6 Inhalation Anesthesia Manufacturer Market Share in 2025
3.5 Inhalation Anesthesia Market: Overall Company Footprint Analysis
  3.5.1 Inhalation Anesthesia Market: Region Footprint
  3.5.2 Inhalation Anesthesia Market: Company Product Type Footprint
  3.5.3 Inhalation Anesthesia Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Inhalation Anesthesia Market Size by Region
  4.1.1 Global Inhalation Anesthesia Sales Quantity by Region (2021-2032)
  4.1.2 Global Inhalation Anesthesia Consumption Value by Region (2021-2032)
  4.1.3 Global Inhalation Anesthesia Average Price by Region (2021-2032)
4.2 North America Inhalation Anesthesia Consumption Value (2021-2032)
4.3 Europe Inhalation Anesthesia Consumption Value (2021-2032)
4.4 Asia-Pacific Inhalation Anesthesia Consumption Value (2021-2032)
4.5 South America Inhalation Anesthesia Consumption Value (2021-2032)
4.6 Middle East & Africa Inhalation Anesthesia Consumption Value (2021-2032)

5 MARKET SEGMENT BY TYPE

5.1 Global Inhalation Anesthesia Sales Quantity by Type (2021-2032)
5.2 Global Inhalation Anesthesia Consumption Value by Type (2021-2032)
5.3 Global Inhalation Anesthesia Average Price by Type (2021-2032)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Inhalation Anesthesia Sales Quantity by Application (2021-2032)
6.2 Global Inhalation Anesthesia Consumption Value by Application (2021-2032)
6.3 Global Inhalation Anesthesia Average Price by Application (2021-2032)

7 NORTH AMERICA

7.1 North America Inhalation Anesthesia Sales Quantity by Type (2021-2032)
7.2 North America Inhalation Anesthesia Sales Quantity by Application (2021-2032)
7.3 North America Inhalation Anesthesia Market Size by Country
  7.3.1 North America Inhalation Anesthesia Sales Quantity by Country (2021-2032)
  7.3.2 North America Inhalation Anesthesia Consumption Value by Country (2021-2032)
  7.3.3 United States Market Size and Forecast (2021-2032)
  7.3.4 Canada Market Size and Forecast (2021-2032)
  7.3.5 Mexico Market Size and Forecast (2021-2032)

8 EUROPE

8.1 Europe Inhalation Anesthesia Sales Quantity by Type (2021-2032)
8.2 Europe Inhalation Anesthesia Sales Quantity by Application (2021-2032)
8.3 Europe Inhalation Anesthesia Market Size by Country
  8.3.1 Europe Inhalation Anesthesia Sales Quantity by Country (2021-2032)
  8.3.2 Europe Inhalation Anesthesia Consumption Value by Country (2021-2032)
  8.3.3 Germany Market Size and Forecast (2021-2032)
  8.3.4 France Market Size and Forecast (2021-2032)
  8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  8.3.6 Russia Market Size and Forecast (2021-2032)
  8.3.7 Italy Market Size and Forecast (2021-2032)

9 ASIA-PACIFIC

9.1 Asia-Pacific Inhalation Anesthesia Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Inhalation Anesthesia Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Inhalation Anesthesia Market Size by Region
  9.3.1 Asia-Pacific Inhalation Anesthesia Sales Quantity by Region (2021-2032)
  9.3.2 Asia-Pacific Inhalation Anesthesia Consumption Value by Region (2021-2032)
  9.3.3 China Market Size and Forecast (2021-2032)
  9.3.4 Japan Market Size and Forecast (2021-2032)
  9.3.5 South Korea Market Size and Forecast (2021-2032)
  9.3.6 India Market Size and Forecast (2021-2032)
  9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  9.3.8 Australia Market Size and Forecast (2021-2032)

10 SOUTH AMERICA

10.1 South America Inhalation Anesthesia Sales Quantity by Type (2021-2032)
10.2 South America Inhalation Anesthesia Sales Quantity by Application (2021-2032)
10.3 South America Inhalation Anesthesia Market Size by Country
  10.3.1 South America Inhalation Anesthesia Sales Quantity by Country (2021-2032)
  10.3.2 South America Inhalation Anesthesia Consumption Value by Country (2021-2032)
  10.3.3 Brazil Market Size and Forecast (2021-2032)
  10.3.4 Argentina Market Size and Forecast (2021-2032)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Inhalation Anesthesia Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Inhalation Anesthesia Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Inhalation Anesthesia Market Size by Country
  11.3.1 Middle East & Africa Inhalation Anesthesia Sales Quantity by Country (2021-2032)
  11.3.2 Middle East & Africa Inhalation Anesthesia Consumption Value by Country (2021-2032)
  11.3.3 Turkey Market Size and Forecast (2021-2032)
  11.3.4 Egypt Market Size and Forecast (2021-2032)
  11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  11.3.6 South Africa Market Size and Forecast (2021-2032)

12 MARKET DYNAMICS

12.1 Inhalation Anesthesia Market Drivers
12.2 Inhalation Anesthesia Market Restraints
12.3 Inhalation Anesthesia Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Inhalation Anesthesia and Key Manufacturers
13.2 Manufacturing Costs Percentage of Inhalation Anesthesia
13.3 Inhalation Anesthesia Production Process
13.4 Industry Value Chain Analysis

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Inhalation Anesthesia Typical Distributors
14.3 Inhalation Anesthesia Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer


LIST OF TABLES

Table 1. Global Inhalation Anesthesia Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Inhalation Anesthesia Consumption Value by MAC, (USD Million), 2021 & 2025 & 2032
Table 3. Global Inhalation Anesthesia Consumption Value by Chemical Structure, (USD Million), 2021 & 2025 & 2032
Table 4. Global Inhalation Anesthesia Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Baxter Basic Information, Manufacturing Base and Competitors
Table 6. Baxter Major Business
Table 7. Baxter Inhalation Anesthesia Product and Services
Table 8. Baxter Inhalation Anesthesia Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Baxter Recent Developments/Updates
Table 10. AbbVie Basic Information, Manufacturing Base and Competitors
Table 11. AbbVie Major Business
Table 12. AbbVie Inhalation Anesthesia Product and Services
Table 13. AbbVie Inhalation Anesthesia Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. AbbVie Recent Developments/Updates
Table 15. Piramal Critical Care Basic Information, Manufacturing Base and Competitors
Table 16. Piramal Critical Care Major Business
Table 17. Piramal Critical Care Inhalation Anesthesia Product and Services
Table 18. Piramal Critical Care Inhalation Anesthesia Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Piramal Critical Care Recent Developments/Updates
Table 20. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 21. Fresenius Kabi Major Business
Table 22. Fresenius Kabi Inhalation Anesthesia Product and Services
Table 23. Fresenius Kabi Inhalation Anesthesia Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Fresenius Kabi Recent Developments/Updates
Table 25. Halocarbon Basic Information, Manufacturing Base and Competitors
Table 26. Halocarbon Major Business
Table 27. Halocarbon Inhalation Anesthesia Product and Services
Table 28. Halocarbon Inhalation Anesthesia Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Halocarbon Recent Developments/Updates
Table 30. Aspen Basic Information, Manufacturing Base and Competitors
Table 31. Aspen Major Business
Table 32. Aspen Inhalation Anesthesia Product and Services
Table 33. Aspen Inhalation Anesthesia Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Aspen Recent Developments/Updates
Table 35. Pfizer Basic Information, Manufacturing Base and Competitors
Table 36. Pfizer Major Business
Table 37. Pfizer Inhalation Anesthesia Product and Services
Table 38. Pfizer Inhalation Anesthesia Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Pfizer Recent Developments/Updates
Table 40. Maruishi Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 41. Maruishi Pharmaceutical Major Business
Table 42. Maruishi Pharmaceutical Inhalation Anesthesia Product and Services
Table 43. Maruishi Pharmaceutical Inhalation Anesthesia Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Maruishi Pharmaceutical Recent Developments/Updates
Table 45. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 46. Jiangsu Hengrui Medicine Major Business
Table 47. Jiangsu Hengrui Medicine Inhalation Anesthesia Product and Services
Table 48. Jiangsu Hengrui Medicine Inhalation Anesthesia Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 50. Lunan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 51. Lunan Pharmaceutical Major Business
Table 52. Lunan Pharmaceutical Inhalation Anesthesia Product and Services
Table 53. Lunan Pharmaceutical Inhalation Anesthesia Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Lunan Pharmaceutical Recent Developments/Updates
Table 55. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Hikma Pharmaceuticals Major Business
Table 57. Hikma Pharmaceuticals Inhalation Anesthesia Product and Services
Table 58. Hikma Pharmaceuticals Inhalation Anesthesia Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Hikma Pharmaceuticals Recent Developments/Updates
Table 60. HeBei YiPin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 61. HeBei YiPin Pharmaceutical Major Business
Table 62. HeBei YiPin Pharmaceutical Inhalation Anesthesia Product and Services
Table 63. HeBei YiPin Pharmaceutical Inhalation Anesthesia Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. HeBei YiPin Pharmaceutical Recent Developments/Updates
Table 65. Dechra Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 66. Dechra Pharmaceuticals Major Business
Table 67. Dechra Pharmaceuticals Inhalation Anesthesia Product and Services
Table 68. Dechra Pharmaceuticals Inhalation Anesthesia Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. Dechra Pharmaceuticals Recent Developments/Updates
Table 70. Life Sciences Basic Information, Manufacturing Base and Competitors
Table 71. Life Sciences Major Business
Table 72. Life Sciences Inhalation Anesthesia Product and Services
Table 73. Life Sciences Inhalation Anesthesia Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Life Sciences Recent Developments/Updates
Table 75. Zhejiang AngLiKang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 76. Zhejiang AngLiKang Pharmaceutical Major Business
Table 77. Zhejiang AngLiKang Pharmaceutical Inhalation Anesthesia Product and Services
Table 78. Zhejiang AngLiKang Pharmaceutical Inhalation Anesthesia Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Zhejiang AngLiKang Pharmaceutical Recent Developments/Updates
Table 80. Linde Healthcare Basic Information, Manufacturing Base and Competitors
Table 81. Linde Healthcare Major Business
Table 82. Linde Healthcare Inhalation Anesthesia Product and Services
Table 83. Linde Healthcare Inhalation Anesthesia Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Linde Healthcare Recent Developments/Updates
Table 85. Air Liquide Basic Information, Manufacturing Base and Competitors
Table 86. Air Liquide Major Business
Table 87. Air Liquide Inhalation Anesthesia Product and Services
Table 88. Air Liquide Inhalation Anesthesia Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Air Liquide Recent Developments/Updates
Table 90. Messer Basic Information, Manufacturing Base and Competitors
Table 91. Messer Major Business
Table 92. Messer Inhalation Anesthesia Product and Services
Table 93. Messer Inhalation Anesthesia Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 94. Messer Recent Developments/Updates
Table 95. Global Inhalation Anesthesia Sales Quantity by Manufacturer (2021-2026) & (Tons)
Table 96. Global Inhalation Anesthesia Revenue by Manufacturer (2021-2026) & (USD Million)
Table 97. Global Inhalation Anesthesia Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 98. Market Position of Manufacturers in Inhalation Anesthesia, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 99. Head Office and Inhalation Anesthesia Production Site of Key Manufacturer
Table 100. Inhalation Anesthesia Market: Company Product Type Footprint
Table 101. Inhalation Anesthesia Market: Company Product Application Footprint
Table 102. Inhalation Anesthesia New Market Entrants and Barriers to Market Entry
Table 103. Inhalation Anesthesia Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Inhalation Anesthesia Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 105. Global Inhalation Anesthesia Sales Quantity by Region (2021-2026) & (Tons)
Table 106. Global Inhalation Anesthesia Sales Quantity by Region (2027-2032) & (Tons)
Table 107. Global Inhalation Anesthesia Consumption Value by Region (2021-2026) & (USD Million)
Table 108. Global Inhalation Anesthesia Consumption Value by Region (2027-2032) & (USD Million)
Table 109. Global Inhalation Anesthesia Average Price by Region (2021-2026) & (US$/kg)
Table 110. Global Inhalation Anesthesia Average Price by Region (2027-2032) & (US$/kg)
Table 111. Global Inhalation Anesthesia Sales Quantity by Type (2021-2026) & (Tons)
Table 112. Global Inhalation Anesthesia Sales Quantity by Type (2027-2032) & (Tons)
Table 113. Global Inhalation Anesthesia Consumption Value by Type (2021-2026) & (USD Million)
Table 114. Global Inhalation Anesthesia Consumption Value by Type (2027-2032) & (USD Million)
Table 115. Global Inhalation Anesthesia Average Price by Type (2021-2026) & (US$/kg)
Table 116. Global Inhalation Anesthesia Average Price by Type (2027-2032) & (US$/kg)
Table 117. Global Inhalation Anesthesia Sales Quantity by Application (2021-2026) & (Tons)
Table 118. Global Inhalation Anesthesia Sales Quantity by Application (2027-2032) & (Tons)
Table 119. Global Inhalation Anesthesia Consumption Value by Application (2021-2026) & (USD Million)
Table 120. Global Inhalation Anesthesia Consumption Value by Application (2027-2032) & (USD Million)
Table 121. Global Inhalation Anesthesia Average Price by Application (2021-2026) & (US$/kg)
Table 122. Global Inhalation Anesthesia Average Price by Application (2027-2032) & (US$/kg)
Table 123. North America Inhalation Anesthesia Sales Quantity by Type (2021-2026) & (Tons)
Table 124. North America Inhalation Anesthesia Sales Quantity by Type (2027-2032) & (Tons)
Table 125. North America Inhalation Anesthesia Sales Quantity by Application (2021-2026) & (Tons)
Table 126. North America Inhalation Anesthesia Sales Quantity by Application (2027-2032) & (Tons)
Table 127. North America Inhalation Anesthesia Sales Quantity by Country (2021-2026) & (Tons)
Table 128. North America Inhalation Anesthesia Sales Quantity by Country (2027-2032) & (Tons)
Table 129. North America Inhalation Anesthesia Consumption Value by Country (2021-2026) & (USD Million)
Table 130. North America Inhalation Anesthesia Consumption Value by Country (2027-2032) & (USD Million)
Table 131. Europe Inhalation Anesthesia Sales Quantity by Type (2021-2026) & (Tons)
Table 132. Europe Inhalation Anesthesia Sales Quantity by Type (2027-2032) & (Tons)
Table 133. Europe Inhalation Anesthesia Sales Quantity by Application (2021-2026) & (Tons)
Table 134. Europe Inhalation Anesthesia Sales Quantity by Application (2027-2032) & (Tons)
Table 135. Europe Inhalation Anesthesia Sales Quantity by Country (2021-2026) & (Tons)
Table 136. Europe Inhalation Anesthesia Sales Quantity by Country (2027-2032) & (Tons)
Table 137. Europe Inhalation Anesthesia Consumption Value by Country (2021-2026) & (USD Million)
Table 138. Europe Inhalation Anesthesia Consumption Value by Country (2027-2032) & (USD Million)
Table 139. Asia-Pacific Inhalation Anesthesia Sales Quantity by Type (2021-2026) & (Tons)
Table 140. Asia-Pacific Inhalation Anesthesia Sales Quantity by Type (2027-2032) & (Tons)
Table 141. Asia-Pacific Inhalation Anesthesia Sales Quantity by Application (2021-2026) & (Tons)
Table 142. Asia-Pacific Inhalation Anesthesia Sales Quantity by Application (2027-2032) & (Tons)
Table 143. Asia-Pacific Inhalation Anesthesia Sales Quantity by Region (2021-2026) & (Tons)
Table 144. Asia-Pacific Inhalation Anesthesia Sales Quantity by Region (2027-2032) & (Tons)
Table 145. Asia-Pacific Inhalation Anesthesia Consumption Value by Region (2021-2026) & (USD Million)
Table 146. Asia-Pacific Inhalation Anesthesia Consumption Value by Region (2027-2032) & (USD Million)
Table 147. South America Inhalation Anesthesia Sales Quantity by Type (2021-2026) & (Tons)
Table 148. South America Inhalation Anesthesia Sales Quantity by Type (2027-2032) & (Tons)
Table 149. South America Inhalation Anesthesia Sales Quantity by Application (2021-2026) & (Tons)
Table 150. South America Inhalation Anesthesia Sales Quantity by Application (2027-2032) & (Tons)
Table 151. South America Inhalation Anesthesia Sales Quantity by Country (2021-2026) & (Tons)
Table 152. South America Inhalation Anesthesia Sales Quantity by Country (2027-2032) & (Tons)
Table 153. South America Inhalation Anesthesia Consumption Value by Country (2021-2026) & (USD Million)
Table 154. South America Inhalation Anesthesia Consumption Value by Country (2027-2032) & (USD Million)
Table 155. Middle East & Africa Inhalation Anesthesia Sales Quantity by Type (2021-2026) & (Tons)
Table 156. Middle East & Africa Inhalation Anesthesia Sales Quantity by Type (2027-2032) & (Tons)
Table 157. Middle East & Africa Inhalation Anesthesia Sales Quantity by Application (2021-2026) & (Tons)
Table 158. Middle East & Africa Inhalation Anesthesia Sales Quantity by Application (2027-2032) & (Tons)
Table 159. Middle East & Africa Inhalation Anesthesia Sales Quantity by Country (2021-2026) & (Tons)
Table 160. Middle East & Africa Inhalation Anesthesia Sales Quantity by Country (2027-2032) & (Tons)
Table 161. Middle East & Africa Inhalation Anesthesia Consumption Value by Country (2021-2026) & (USD Million)
Table 162. Middle East & Africa Inhalation Anesthesia Consumption Value by Country (2027-2032) & (USD Million)
Table 163. Inhalation Anesthesia Raw Material
Table 164. Key Manufacturers of Inhalation Anesthesia Raw Materials
Table 165. Inhalation Anesthesia Typical Distributors
Table 166. Inhalation Anesthesia Typical Customers

LIST OF FIGURES

Figure 1. Inhalation Anesthesia Picture
Figure 2. Global Inhalation Anesthesia Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Inhalation Anesthesia Revenue Market Share by Type in 2025
Figure 4. Heptafluoroane Examples
Figure 5. Desflurane Examples
Figure 6. Isoflurane Examples
Figure 7. Others Examples
Figure 8. Global Inhalation Anesthesia Revenue by MAC, (USD Million), 2021 & 2025 & 2032
Figure 9. Global Inhalation Anesthesia Revenue Market Share by MAC in 2025
Figure 10. Below 3% Examples
Figure 11. Above 3% Examples
Figure 12. Global Inhalation Anesthesia Revenue by Chemical Structure, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Inhalation Anesthesia Revenue Market Share by Chemical Structure in 2025
Figure 14. Volatile Gases Examples
Figure 15. Liquids Examples
Figure 16. Global Inhalation Anesthesia Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Global Inhalation Anesthesia Revenue Market Share by Application in 2025
Figure 18. Human Use Examples
Figure 19. Animal Use Examples
Figure 20. Global Inhalation Anesthesia Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 21. Global Inhalation Anesthesia Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 22. Global Inhalation Anesthesia Sales Quantity (2021-2032) & (Tons)
Figure 23. Global Inhalation Anesthesia Price (2021-2032) & (US$/kg)
Figure 24. Global Inhalation Anesthesia Sales Quantity Market Share by Manufacturer in 2025
Figure 25. Global Inhalation Anesthesia Revenue Market Share by Manufacturer in 2025
Figure 26. Producer Shipments of Inhalation Anesthesia by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 27. Top 3 Inhalation Anesthesia Manufacturer (Revenue) Market Share in 2025
Figure 28. Top 6 Inhalation Anesthesia Manufacturer (Revenue) Market Share in 2025
Figure 29. Global Inhalation Anesthesia Sales Quantity Market Share by Region (2021-2032)
Figure 30. Global Inhalation Anesthesia Consumption Value Market Share by Region (2021-2032)
Figure 31. North America Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 32. Europe Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 33. Asia-Pacific Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 34. South America Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 35. Middle East & Africa Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 36. Global Inhalation Anesthesia Sales Quantity Market Share by Type (2021-2032)
Figure 37. Global Inhalation Anesthesia Consumption Value Market Share by Type (2021-2032)
Figure 38. Global Inhalation Anesthesia Average Price by Type (2021-2032) & (US$/kg)
Figure 39. Global Inhalation Anesthesia Sales Quantity Market Share by Application (2021-2032)
Figure 40. Global Inhalation Anesthesia Revenue Market Share by Application (2021-2032)
Figure 41. Global Inhalation Anesthesia Average Price by Application (2021-2032) & (US$/kg)
Figure 42. North America Inhalation Anesthesia Sales Quantity Market Share by Type (2021-2032)
Figure 43. North America Inhalation Anesthesia Sales Quantity Market Share by Application (2021-2032)
Figure 44. North America Inhalation Anesthesia Sales Quantity Market Share by Country (2021-2032)
Figure 45. North America Inhalation Anesthesia Consumption Value Market Share by Country (2021-2032)
Figure 46. United States Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 47. Canada Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 48. Mexico Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 49. Europe Inhalation Anesthesia Sales Quantity Market Share by Type (2021-2032)
Figure 50. Europe Inhalation Anesthesia Sales Quantity Market Share by Application (2021-2032)
Figure 51. Europe Inhalation Anesthesia Sales Quantity Market Share by Country (2021-2032)
Figure 52. Europe Inhalation Anesthesia Consumption Value Market Share by Country (2021-2032)
Figure 53. Germany Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 54. France Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 55. United Kingdom Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 56. Russia Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 57. Italy Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 58. Asia-Pacific Inhalation Anesthesia Sales Quantity Market Share by Type (2021-2032)
Figure 59. Asia-Pacific Inhalation Anesthesia Sales Quantity Market Share by Application (2021-2032)
Figure 60. Asia-Pacific Inhalation Anesthesia Sales Quantity Market Share by Region (2021-2032)
Figure 61. Asia-Pacific Inhalation Anesthesia Consumption Value Market Share by Region (2021-2032)
Figure 62. China Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 63. Japan Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 64. South Korea Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 65. India Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 66. Southeast Asia Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 67. Australia Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 68. South America Inhalation Anesthesia Sales Quantity Market Share by Type (2021-2032)
Figure 69. South America Inhalation Anesthesia Sales Quantity Market Share by Application (2021-2032)
Figure 70. South America Inhalation Anesthesia Sales Quantity Market Share by Country (2021-2032)
Figure 71. South America Inhalation Anesthesia Consumption Value Market Share by Country (2021-2032)
Figure 72. Brazil Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 73. Argentina Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 74. Middle East & Africa Inhalation Anesthesia Sales Quantity Market Share by Type (2021-2032)
Figure 75. Middle East & Africa Inhalation Anesthesia Sales Quantity Market Share by Application (2021-2032)
Figure 76. Middle East & Africa Inhalation Anesthesia Sales Quantity Market Share by Country (2021-2032)
Figure 77. Middle East & Africa Inhalation Anesthesia Consumption Value Market Share by Country (2021-2032)
Figure 78. Turkey Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 79. Egypt Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 80. Saudi Arabia Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 81. South Africa Inhalation Anesthesia Consumption Value (2021-2032) & (USD Million)
Figure 82. Inhalation Anesthesia Market Drivers
Figure 83. Inhalation Anesthesia Market Restraints
Figure 84. Inhalation Anesthesia Market Trends
Figure 85. Porters Five Forces Analysis
Figure 86. Manufacturing Cost Structure Analysis of Inhalation Anesthesia in 2025
Figure 87. Manufacturing Process Analysis of Inhalation Anesthesia
Figure 88. Inhalation Anesthesia Industrial Chain
Figure 89. Sales Channel: Direct to End-User vs Distributors
Figure 90. Direct Channel Pros & Cons
Figure 91. Indirect Channel Pros & Cons
Figure 92. Methodology
Figure 93. Research Process and Data Source


More Publications